Although SPECT MPI is widely used, it is also associated with a relatively high radiation dose. While there is a considerable worldwide variation, SPECT MPI has the highest per capita radiation dose of all medical tests, [9] [10] [11] contributing to approximately 10% of the cumulative radiation dose of medical procedures in the United States. 12 The authors of the IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS) rightfully concluded that the significant relationship between best-practice implementation and lower doses indicates numerous opportunities to reduce radiation exposure from MPI globally. 13 Although exposure to radiation should be handled with care, it is essential to realize that the estimation of risk from ionizing radiation is difficult, especially since no prospective trials focusing on adverse events due to radiation from diagnostic procedures have ever been performed. 14 Despite the (small) possible risk to patients' health, investigations involving radiation are an accepted and fundamental part of medical practice. However, the awareness of medical doctors on the actual radiation doses received by patients of the commonly requested radiological investigations is limited. Using a questionnaire, Shiralkar et al. showed that 97% of the answers were underestimates of the actual dose; six (5%) doctors did not realize that ultrasound does not use ionizing radiation; and 11 (8%) did not realize that magnetic resonance imaging does not use ionizing radiation. 15 Perhaps even more troubling is the fact that even those working in medical imaging are not fully aware of the possible risks of radiation exposure related to medical procedures. In one study of U.S. health care providers using CT in patients with abdominal and flank pain, less than 50% of radiologists and only 9% of emergency department physicians reported even being aware that CT was associated with a possible increased risk of cancer. 16 The latter may partially explain why the awareness of the necessity to reduce radiation doses related to SPECT MPI has been slow to manifest. Additionally, there were historical transatlantic differences and discussions related to concerns whether a reduced administered dose could have the same highly appreciated diagnostic and prognostic properties of higher dose protocols. This is perhaps best illustrated by a reviewer comment (most likely based in the US) from the late nineties of the previous century on one of our (European based) manuscripts submitted to the Journal of Nuclear Cardiology: ''Two-day sestamibi protocol with 400 MBq. In my obsolete units this was about 11mCI. Was the dose really that low?''.
Since that area and post or propter of these transatlantic differences, the awareness to reduce radiation dose from diagnostic procedures has grown rapidly. It is tempting to make an analogy with the illustrated story of the Very Hungry Caterpillar by Eric Carle published in 1969, with its then very innovative design with holes ''eaten'' through the pages. One Sunday morning, a red-faced caterpillar hatches from an egg, and begins to look for some food. He eats through increasing quantities of fruit on the following 5 days: one apple on Monday, two pears on Tuesday, three plums on Wednesday, four strawberries on Thursday, and five oranges on Friday, and then, on Saturday, he has an enormous feast. By the end of Saturday, the inevitable happens and he is ill. After recovering from a stomach-ache, he returns to a more sensible diet by eating through a large green leaf before spinning a cocoon in which he remains for the following 2 weeks. Later, the ''big fat caterpillar'' emerges as a beautiful butterfly with large, gorgeous, multi-colored wings. We could call our caterpillar the dose reduction caterpillar and wonder whether the pupal case has been broken and we have emerged as a beautiful butterfly.
The dose reduction caterpillar has been very hungry and many attempts have been made to reduce the relatively high dose associated with SPECT MPI. Introduction of stress-only protocols reduced the radiation dose by 63% without reducing its prognostic value. 17 Moreover, applying attenuation correction can further reduce this dose by an additional 16% due to an increase in normalcy rate and lower need for additional rest imaging. [18] [19] [20] In addition, multiple studies showed that the introduction of new generation cadmium zinc telluride (CZT)-based SPECT cameras allowed for further dose reduction. [21] [22] [23] These new cameras rely on a pinhole collimation design and multiple CZT crystal arrays. Compared to the traditional SPECT camera, this type of collimation provides a three-to five-fold increase in photon sensitivity, thereby reducing imaging times significantly, while providing a 1.7 to 2.5-fold increase in spatial resolution. This makes shorter scans or lower doses (or even both) a reality, without the loss of image quality. Despite these improvements in dose reduction, the caterpillar is still hungry for improvement.
One of the aspects that so far had not been addressed fully is the lowest product of tracer activity and scan time (PAST) that has no effects on the diagnostic outcome in CZT-SPECT MPI. Thus far, previous studies have shown that body-weight dependent activity protocols not only resulted in an improved image quality but also in the possibility to further lower the tracer activity. 24, 25 However, prognostic evidence that such a low body-weight dependent activity protocol with limited scan time does not affect diagnostic outcome was lacking.
In this issue of the Journal of Nuclear Cardiology Van Dijk et al. have addressed this issue and compared a standard fixed-activity protocol (FAP) and a patientspecific low-activity protocol (PLAP) with regard to percentage of scans interpreted as normal, radiation dose, and prognostic value for CZT-SPECT MPI. 26 1255 consecutive patients were included retrospectively who underwent CZT-SPECT stress-optional rest MPI. 668 Patients were scanned using FAP (370 MBq) and 587 patients using PLAP (2.25 MBq/kg). The percentage of scans interpreted as normal was 67% in FAP and 70% in PLAP groups (P = 0.29). The annualized hard event rates in these patients were 1.0% in the FAP and 0.9% in the PLAP group (P = 0.86). However, the mean radiation dose decreased by 23% for stress-only and by 15% to 2.6 mSv for stress-rest MPI after introduction of the PLAP (P \ 0.001). The authors rightfully concluded that the introduction of a patient-specific lowactivity protocol did not affect the percentage of scans interpreted as normal or prognosis but significantly lowered the radiation dose for CZT-SPECT MPI.
Although the relatively low event rates in this study may have introduced statistical variation, this effect is most likely limited as event rates were similar to other publications. In addition, it is important to realize that the study was performed on a CZT-based camera instead of a more commonly used conventional Anger camera. However, it seems safe to assume that introduction of patient-specific activity or scan-time protocols as derived for conventional SPECT cameras may allow radiation dose reductions without affecting diagnostic outcomes in these cameras as well.
Last but not least it is important to realize that the total radiation dose in this protocol is defined by the additional and separate CT scans for attenuation correction and coronary artery calcification scoring. If we assume the cumulated radiation from CT at 3 to 4 mSv this means that the total reduction is less pronounced and almost halved.
Nevertheless the study by Van Dijk et al. has shown that we can further reduce radiation dose for SPECT MPI while maintaining diagnostic and prognostic properties. The question remains whether the Very Hungry Caterpillar has already broken the pupal case to emerge as a beautiful butterfly. The pupal case has not been broken completely yet, but the first cracks are there. The efforts to reduce radiation burden from diagnostic procedures in general and SPECT MPI specifically are an ever ongoing process that should continue until we finally emerge as a beautiful butterfly.
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